Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 12,745 | 13,328 | 13,704 | 12,002 | 12,548 |
| Operating Income | -12,745 | -13,328 | -13,704 | -12,002 | -12,548 |
| Other Income | 10,455 | -1,337 | 12,784 | -14,641 | 4,607 |
| Pre-tax Income | -2,289 | -14,665 | -919 | -26,642 | -7,941 |
| Net Income Continuous | -2,355 | -14,665 | -919 | -26,642 | -7,881 |
| Net Income | $-2,355 | $-14,665 | $-919 | $-26,642 | $-7,881 |
| EPS Basic Total Ops | 2.76 | -11.18 | -0.77 | -27.33 | -12.31 |
| EPS Basic Continuous Ops | 2.70 | -11.18 | -0.77 | -27.26 | -12.25 |
| EPS Diluted Total Ops | 3.00 | -12.13 | -5.43 | -27.33 | -12.31 |
| EPS Diluted Continuous Ops | 3.05 | -11.06 | -0.74 | -27.26 | -12.25 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -16.52 | -15.32 | N/A | N/A |
| EBITDA(a) | $-12,676 | $-13,259 | $-13,638 | $-11,913 | $-12,478 |